|
EPS15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08430000000936E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.56710000000549E-05 |
| Normal-vs-Stage2 |
1.321590E-01 |
| Normal-vs-Stage3 |
4.16349999999843E-05 |
| Normal-vs-Stage4 |
8.76570000030163E-07 |
| Stage1-vs-Stage2 |
6.338800E-01 |
| Stage1-vs-Stage3 |
2.896600E-01 |
| Stage1-vs-Stage4 |
8.972100E-02 |
| Stage2-vs-Stage3 |
3.167200E-01 |
| Stage2-vs-Stage4 |
1.884980E-01 |
| Stage3-vs-Stage4 |
6.406600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65537999999854E-05 |
| Normal-vs-AfricanAmerican |
1.4741999843082E-09 |
| Normal-vs-Asian |
3.394000E-01 |
| Caucasian-vs-AfricanAmerican |
8.213000E-04 |
| Caucasian-vs-Asian |
7.878200E-02 |
| AfricanAmerican-vs-Asian |
9.448300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.48740000000581E-07 |
| Normal-vs-Female |
4.564500E-04 |
| Male-vs-Female |
3.119200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.209200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.044450E-03 |
| Normal-vs-Age(61-80Yrs) |
6.07749999992357E-07 |
| Normal-vs-Age(81-100Yrs) |
1.561700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.177000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.639800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.566600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.337770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.079200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.367800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.344800E-01 |
| Normal-vs-Grade 2 |
1.572100E-02 |
| Normal-vs-Grade 3 |
1.28039999713891E-08 |
| Normal-vs-Grade 4 |
2.74129999999762E-06 |
| Grade 1-vs-Grade 2 |
8.406600E-01 |
| Grade 1-vs-Grade 3 |
9.870000E-02 |
| Grade 1-vs-Grade 4 |
1.432210E-01 |
| Grade 2-vs-Grade 3 |
2.039400E-03 |
| Grade 2-vs-Grade 4 |
1.354070E-02 |
| Grade 3-vs-Grade 4 |
8.573600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.310200E-02 |
| Normal-vs-ccB subtype |
4.78270000003889E-06 |
| ccA subtype-vs-ccB subtype |
5.362300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.416970E-04 |
| Normal-vs-N1 |
1.982230E-01 |
| N0-vs-N1 |
9.219000E-01 |
|
|
